Page results
-
Geoff Bellingan was appointed Medical Director in September 2009. He previously held posts as Clinical Director and Divisional Clinical Director between 2006 and 2009.
-
Gill was Medical Director for the Specialist Hospitals Board from 2010-2019 and was appointed as medical director, digital healthcare, in October 2019.
-
Tim Hodgson, Consultant in Oral Medicine and Honorary Associate Professor, was appointed Medical Director of the Specialist Hospitals Board UCLH Foundation NHS Trust in November 2019 and joined the Board as an Executive Director in January 2020.
-
Charles House was appointed Medical Director in July 2017 having previously been the interim Medical Director since March 2016.
-
Patient story - Zehavah Handler - When sleep becomes a nightmare. Zehavah Handler struggled to sleep for 25 years before completing a five-week course at UCLH’s insomnia clinic. Here, she tells us how it changed her life.
-
Last year, UCLH Arts & Heritage and our resident doctor community worked collaboratively to run a series of 10 creative workshops looking at various art-making methods aimed at improving the well being of doctors.
-
UCLH is committed to not only treat patients’ illnesses but to provide an environment and an experience which contributes to patients’ general wellbeing.
-
Latest issues of our Haematology Life magazine
-
Mark Emberton joined the board as a non-executive director on 1 September 2022. He is Professor of Intervention Oncology within the Division of Surgery and Dean of the Faculty of Medical Science at University College London.
-
Today, 11 February, marks the tenth anniversary of the International Day of Women and Girls in Science, which seeks to bring gender equality in science and promote role models to inspire girls and women into scientific professions.
File results
-
FOI/2024/0694 - Off-framework agency shifts/ spend/ contact details January-August 2024
-
FOI/2024/0702 - Community respiratory service mapping/ community-based bronchiectasis services
-
FOI/2024/0703 - Neurofibromatosis type 1 treatment/ volume of medication dispensed
-
FOI/2024/0704 - Contingencies to support visitors/ patients/ contractors witnessing a distressing event
-
FOI/2024/0716 - Toxicological screening/ testing/ training and information to patients
-
FOI/2024/0718 - Mental health/ electronic health records software/ dermatology screening/ imaging services/ medical devices for wound care
-
FOI/2024/0721 - New biologic and targeted medications/ treatment within dermatology
-
FOI/2024/0727 - Clinical photography solution contract/ spend
-
FOI/2024/0740 - A&E tooth decay admissions for 2021/22, 2022/23 and 2023/24
-
FOI/2024/0741 - HR, finance and payroll contracts/ software updates/ staff contact details